FC
KRRO icon

FORA Capital’s Korro Bio KRRO Stock Holding History

FORA Capital’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26
Closed -$30K – 828
2020
Q2 		$30K Buy
+26
New +$23.5K 0.01% 744

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
MS
Mizuho Securities Tokyo, Japan $7.68M AUM 15.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FORA Capital's KRRO Position: Q3 2020 in Review

FORA Capital sold out of Korro Bio (KRRO) in Q3 2020, closing a stake of 26 shares — an estimated $30K sold.

FORA Capital first reported a position in KRRO in Q2 2020 and held it in 1 quarter. The position peaked at $30K in Q2 2020. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2020.

  • FORA Capital reported no remaining Korro Bio position as of Q3 2020 after selling out during the quarter.
  • FORA Capital sold 26 Korro Bio shares in Q3 2020, an estimated $30K.
  • FORA Capital first reported a position in Korro Bio in Q2 2020 and held it in 1 quarter.
  • FORA Capital's Korro Bio position peaked at $30K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2020.

Based on FORA Capital's 13F filing for Q3 2020, filed 13 Nov 2020.